AllianceBernstein’s Cabaletta Bio CABA Stock Holding History

AllianceBernstein’s Portfolio CABA Stock Details CABA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-64,630	Closed	-$89.5K	–	3247
2025 Q1	$89.5K	Hold	64,630	–	–	﹤0.01%	3079
2024 Q4	$147K	Hold	64,630	–	–	﹤0.01%	3078
2024 Q3	$305K	Hold	64,630	–	–	﹤0.01%	2909
2024 Q2	$483K	Buy	64,630 +33,320	+106%	+$408K	﹤0.01%	2692
2024 Q1	$534K	Sell	31,310 -62,022	-66%	-$1.33M	﹤0.01%	2559
2023 Q4	$2.12M	Sell	93,332 -72,071	-44%	-$1.21M	﹤0.01%	1903
2023 Q3	$2.52M	Buy	165,403 +154,303	+1,390%	+$2.11M	﹤0.01%	1760
2023 Q2	$143K	Buy	+11,100	New	+$120K	﹤0.01%	3042

Other funds holding CABA

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HCM

Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JFG

Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

AllianceBernstein's CABA Position: Q2 2025 in Review

AllianceBernstein sold out of Cabaletta Bio (CABA) in Q2 2025, closing a stake of 64,630 shares — an estimated $89.5K sold.

AllianceBernstein first reported a position in CABA in Q2 2023 and held it in 8 quarters. The position peaked at $2.52M in Q3 2023. 86 funds tracked by Wall St. Rank hold CABA as of Q2 2025.

AllianceBernstein reported no remaining Cabaletta Bio position as of Q2 2025 after selling out during the quarter.
AllianceBernstein sold 64,630 Cabaletta Bio shares in Q2 2025, an estimated $89.5K.
AllianceBernstein first reported a position in Cabaletta Bio in Q2 2023 and held it in 8 quarters.
AllianceBernstein's Cabaletta Bio position peaked at $2.52M in Q3 2023.
86 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2025.

Based on AllianceBernstein's 13F filing for Q2 2025, filed 14 Aug 2025.